Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
06 10월 2023 - 5:30AM
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company
pioneering a novel technology for bioengineering fully
transplantable organs to help save and improve patients' lives,
today announced that CEO Jeff Ross will present at the 2023 Cell
& Gene Meeting on the Mesa in Carlsbad, CA. The three-day
event, held this year on October 10-12, will feature presentations
by leading public and private companies, highlighting technical and
clinical achievements over the past 12 months in the areas of cell
therapy, gene therapy, gene editing, tissue engineering, and
broader regenerative medicine technologies.
Mr. Ross will deliver his remarks at 5:30 pm PT on Wednesday,
October 11th in the Ecolab Lifesciences Ballroom. Registration for
either in-person attendance or virtual participation is available
here.
About MiromatrixMiromatrix Medical Inc. is
a life sciences company pioneering a novel technology for
bioengineering fully transplantable human organs to help save and
improve patients' lives. The Company has developed a proprietary
perfusion technology platform for bioengineering organs that it
believes will efficiently scale to address the shortage of
available human organs. The Company's initial development focus is
on human livers and kidneys. For more information,
visit miromatrix.com.
Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com
Media Contact:
Christina Campbell
612-924-3793
Christina@media-minefield.com
MiroMatrix Medical (NASDAQ:MIRO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
MiroMatrix Medical (NASDAQ:MIRO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024